OTC · INBP · USD

Integrated BioPharma, Inc. (INBP)

Stock price, earnings

Track INBP in PortfolioX

$0.17$0.00 (0.0%)Pre-market

Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.

A year in perspective

One-year closing-price history · USD. Historical prices are not a forecast.

Integrated BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.52% below the high.

At a glance

Market cap: $5.28M
P/E ratio: -1.86
Dividend yield: —
Volume: 16.49K

52-week range

$0.14$0.42

Go beyond this overview with deeper company research in PortfolioX. Explore more in the app

BEHIND THE RESULTS

Integrated BioPharma, Inc. earnings

How to read these results →

Earnings calendar

Estimates

Reporting date: Not announced
Fiscal period: —
Estimated EPS: —
Estimated revenue: —

Upcoming dates and analyst estimates may change. Fiscal quarters follow Integrated BioPharma, Inc.’s reporting calendar.

Past earnings

Actual results · USD

Integrated BioPharma, Inc. earnings results and percentage differences versus estimates
Fiscal period	Reported	EPS	Revenue
Q4 2026	Sep 25, 2026	-$0.04	$10.11M
Q4 2026	Sep 25, 2026	-$0.04	$9.80M
Q2 2026	Feb 11, 2026	-$0.03	$11.28M
Q1 2026	Nov 10, 2025	$0.00	$0.00
Q4 2025	Sep 23, 2025	-$0.01	$14.18M
Q3 2025	May 14, 2025	$0.02	$13.95M
Q2 2025	Feb 13, 2025	$0.00	$12.61M
Q1 2025	Nov 13, 2024	$0.01	$25.86M

PUT THE NUMBERS IN CONTEXT

Valuation, profitability & financial health

Keep researching in the app

Valuation

P/E ratio5-year median: 13.37×: -1.86×
Price / sales5-year median: 0.20×: 0.12×
Price / free cash flow5-year median: 6.25×: 5.90×
Enterprise value / EBITDA5-year median: 4.42×: -2.86×

Profitability

Gross margin5-year median: 8.01%: 1.82%
Operating margin5-year median: 0.5%: -6.17%
Net margin5-year median: 0.22%: -6.48%
Return on invested capital5-year median: 0.5%: -13.04%

Financial health

Current ratio5-year median: 3.16×: 3.00×
Quick ratio5-year median: 1.27×: 1.42×
Debt / equity5-year median: 0.11×: 0.17×
Net debt / EBITDA5-year median: 0.48×: 1.02×

Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.

THE COMPANY BEHIND THE TICKER

About Integrated BioPharma, Inc.

Integrated BioPharma, Inc.

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO: Riva Sheppard
Employees: 134

Shareholder metrics

Free cash flow per share: $0.03
Revenue per share: $1.41
Book value per share: $0.57
Dividend payout ratio: —

Latest available per-share figures in USD. The payout ratio compares dividends with earnings.

About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.

Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.